Stem cells as a source of regenerative cardiomyocytes

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

The realization of regenerative cardiac medicine depends on the availability of cardiomyocytes in sufficient numbers for transplantation of cardiac tissue and the accompanying blood vessels. Embryonic stem (ES) cells, bone marrow (BM) stem cells, and tissue-derived stem cells are all potential cell sources. Although ES cells are highly proliferative and suitable for mass production, an efficient protocol is yet to be established to ensure selective cardiomyocyte induction using these cells. Recent advances in developmental biology have clarified the involvement of critical factors in cardiomyocyte differentiation, including bone morphogenic protein and Wnt signaling proteins, and such factors have the potential to improve the efficiency of stem cell induction. Initial studies of the intracoronary administration of BM mononuclear cells after myocardial infarction has yielded promising results; however, intensive investigation of the underlying molecular mechanisms at play as well as double-blinded clinical trials will be necessary to establish the extent of both migration of the BM stem cells into the damaged cardiac tissue and their differentiation into cardiomyocytes. Several types of cardiac tissue stem cells have also been reported, but an accurate and extensive comparison of these cells with regard to their characteristics and multipotency remains to be done. An integrative study involving developmental biology, stem cell biology, and tissue engineering is required to achieve the full potential of cardiac regeneration.

Original languageEnglish
Pages (from-to)1002-1013
Number of pages12
JournalCirculation Research
Volume98
Issue number8
DOIs
Publication statusPublished - 2006 Apr

Fingerprint

Cardiac Myocytes
Stem Cells
Bone Marrow Cells
Developmental Biology
Embryonic Stem Cells
Wnt Proteins
Cell Engineering
Tissue Transplantation
Regenerative Medicine
Heart Transplantation
Tissue Engineering
Blood Vessels
Cell Biology
Regeneration
Myocardial Infarction
Clinical Trials
Bone and Bones
Proteins

Keywords

  • Cardiomyocyte
  • Cell transplantation
  • Differentiation
  • Stem cell
  • Tissue engineering

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Stem cells as a source of regenerative cardiomyocytes. / Fukuda, Keiichi; Yuasa, Shinsuke.

In: Circulation Research, Vol. 98, No. 8, 04.2006, p. 1002-1013.

Research output: Contribution to journalArticle

@article{a3b49bf574c2429584ec03a052d24717,
title = "Stem cells as a source of regenerative cardiomyocytes",
abstract = "The realization of regenerative cardiac medicine depends on the availability of cardiomyocytes in sufficient numbers for transplantation of cardiac tissue and the accompanying blood vessels. Embryonic stem (ES) cells, bone marrow (BM) stem cells, and tissue-derived stem cells are all potential cell sources. Although ES cells are highly proliferative and suitable for mass production, an efficient protocol is yet to be established to ensure selective cardiomyocyte induction using these cells. Recent advances in developmental biology have clarified the involvement of critical factors in cardiomyocyte differentiation, including bone morphogenic protein and Wnt signaling proteins, and such factors have the potential to improve the efficiency of stem cell induction. Initial studies of the intracoronary administration of BM mononuclear cells after myocardial infarction has yielded promising results; however, intensive investigation of the underlying molecular mechanisms at play as well as double-blinded clinical trials will be necessary to establish the extent of both migration of the BM stem cells into the damaged cardiac tissue and their differentiation into cardiomyocytes. Several types of cardiac tissue stem cells have also been reported, but an accurate and extensive comparison of these cells with regard to their characteristics and multipotency remains to be done. An integrative study involving developmental biology, stem cell biology, and tissue engineering is required to achieve the full potential of cardiac regeneration.",
keywords = "Cardiomyocyte, Cell transplantation, Differentiation, Stem cell, Tissue engineering",
author = "Keiichi Fukuda and Shinsuke Yuasa",
year = "2006",
month = "4",
doi = "10.1161/01.RES.0000218272.18669.6e",
language = "English",
volume = "98",
pages = "1002--1013",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Stem cells as a source of regenerative cardiomyocytes

AU - Fukuda, Keiichi

AU - Yuasa, Shinsuke

PY - 2006/4

Y1 - 2006/4

N2 - The realization of regenerative cardiac medicine depends on the availability of cardiomyocytes in sufficient numbers for transplantation of cardiac tissue and the accompanying blood vessels. Embryonic stem (ES) cells, bone marrow (BM) stem cells, and tissue-derived stem cells are all potential cell sources. Although ES cells are highly proliferative and suitable for mass production, an efficient protocol is yet to be established to ensure selective cardiomyocyte induction using these cells. Recent advances in developmental biology have clarified the involvement of critical factors in cardiomyocyte differentiation, including bone morphogenic protein and Wnt signaling proteins, and such factors have the potential to improve the efficiency of stem cell induction. Initial studies of the intracoronary administration of BM mononuclear cells after myocardial infarction has yielded promising results; however, intensive investigation of the underlying molecular mechanisms at play as well as double-blinded clinical trials will be necessary to establish the extent of both migration of the BM stem cells into the damaged cardiac tissue and their differentiation into cardiomyocytes. Several types of cardiac tissue stem cells have also been reported, but an accurate and extensive comparison of these cells with regard to their characteristics and multipotency remains to be done. An integrative study involving developmental biology, stem cell biology, and tissue engineering is required to achieve the full potential of cardiac regeneration.

AB - The realization of regenerative cardiac medicine depends on the availability of cardiomyocytes in sufficient numbers for transplantation of cardiac tissue and the accompanying blood vessels. Embryonic stem (ES) cells, bone marrow (BM) stem cells, and tissue-derived stem cells are all potential cell sources. Although ES cells are highly proliferative and suitable for mass production, an efficient protocol is yet to be established to ensure selective cardiomyocyte induction using these cells. Recent advances in developmental biology have clarified the involvement of critical factors in cardiomyocyte differentiation, including bone morphogenic protein and Wnt signaling proteins, and such factors have the potential to improve the efficiency of stem cell induction. Initial studies of the intracoronary administration of BM mononuclear cells after myocardial infarction has yielded promising results; however, intensive investigation of the underlying molecular mechanisms at play as well as double-blinded clinical trials will be necessary to establish the extent of both migration of the BM stem cells into the damaged cardiac tissue and their differentiation into cardiomyocytes. Several types of cardiac tissue stem cells have also been reported, but an accurate and extensive comparison of these cells with regard to their characteristics and multipotency remains to be done. An integrative study involving developmental biology, stem cell biology, and tissue engineering is required to achieve the full potential of cardiac regeneration.

KW - Cardiomyocyte

KW - Cell transplantation

KW - Differentiation

KW - Stem cell

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=33646789159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646789159&partnerID=8YFLogxK

U2 - 10.1161/01.RES.0000218272.18669.6e

DO - 10.1161/01.RES.0000218272.18669.6e

M3 - Article

C2 - 16645150

AN - SCOPUS:33646789159

VL - 98

SP - 1002

EP - 1013

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 8

ER -